Delivery Order SPE2DB20D3303-SPE2DB25FA1UV
- Not listed
- The Defense Logistics Agency awarded a $5,772.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP vaccine vials (0.5ml) on August 21, 2025, with completion targeted for August 22, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime contract vehicle (SPE2DX) running through December 2026 that provides comprehensive pharmaceutical and medical supply...
- The Defense Logistics Agency awarded a $46,590.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP syringes (0.5mL) with an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside delivery order represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a $1,358.05 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Adacel TDAP vaccine in 0.5 mL vials. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and represents a non-competitive set-aside award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $33,190.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP Syringe 0.5ML with an ultimate completion date of August 25, 2025. This is a competitively awarded contract with no set-aside designation, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $1,340.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Adacel TDAP syringes (0.5mL) on July 25, 2025, with an ultimate completion date of July 28, 2025. This is a non-set-aside competitive award, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain on September 15, 2025, for the supply of Adacel TDAP vaccine in 0.5ml vials. The contract represents a firm fixed-price delivery order with a ceiling value of $2,094.55 and an ultimate completion date of September 16, 2025. This award was made on a competitive basis with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP Syringe 0.5ML on September 12, 2025, with a ceiling value of $16,221.54 and firm fixed pricing. This non-set-aside, competitively awarded contract represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $4,690.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP syringes (0.5ML) with a completion date of September 3, 2025. The contract, which was competitively awarded without set-aside designation, represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a $18,973.02 delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP syringe 0.5ML under a firm fixed-price contract type with an ultimate completion date of August 13, 2025. This non-set-aside award is being performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor supporting military and...
- The Defense Logistics Agency awarded a $33.5K delivery order to AmerisourceBergen Drug Corp for Adacel TDAP syringes (0.5mL) under a firm fixed-price contract with a completion date of September 4, 2025. This non-set-aside competitive award leverages AmerisourceBergen's position as a critical pharmaceutical and medical supply vendor for federal healthcare procurement. The order was placed to the company's corporate office location in Conshohocken, Pennsylvania, where the company is headquartered...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1UVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,281.17 to AmerisourceBergen Drug Corp for ADACEL TDAP vaccine vials (0.5mL) on July 28, 2025, with a completion date of July 29, 2025. This firm fixed-price, non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and supplies pharmaceutical products and medical supplies to support military healthcare programs worldwide. The place of performance for this order is located at AmerisourceBergen's corporate office in Conshohocken, PA 19428. This delivery order represents a routine procurement under the DLA's Pharmaceutical Prime Vendor Global Program, which leverages AmerisourceBergen's comprehensive distribution capabilities to fulfill immunization requirements across the Defense Health Agency and other federal healthcare systems. The ADACEL vaccine is a combination immunization product commonly administered to military personnel and beneficiaries, and this order reflects the ongoing operational vaccine supply needs of the federal military healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 7/28/25 |